structure
1 child cluster
Sub-clusters inside Metabolic Health & Cancer Research. Each card links to its own detail page; counts are rolled up through the whole subtree of that child.
organizations
2 orgs in this cluster's subtree
Every organization with primary activities in Metabolic Health & Cancer Research or any of its descendants. Click a column header to sort. Filter by name or state above the table.
showing 2 of 2
| # | Organization | State | Revenue | Activities ↓ |
|---|---|---|---|---|
| 1 | METABOLIC TERRAIN INSTITUTE OF HEALTH I Metabolic Terrain Institute of Health I is an organization focused on advancing metabolic health and integrative approaches to chronic illness and cancer. It p… | AZ | $265K | 7 |
| 2 | THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE The Translational Genomics Research Institute (TGen), part of City of Hope, conducts genomic research to understand and treat complex diseases like cancer, neu… | AZ | $47.8M | 2 |
theories of action
strategies used in this cluster
Theories of action extracted from orgs in this subtree. Click any to see the full set of orgs running the same approach.
- Root Cause Resolution 1 orgBy identifying and correcting underlying biochemical, metabolic, and emotional imbalances, organizations enable sustained healing and disease prevention, because these imbalances are believed to be the foundational drivers of chronic illness and declining wellness. This strategy centers on a systems-level understanding of health, where symptoms are seen as manifestations of deeper dysregulation in metabolism, immunity, or emotional biology. Unlike symptom-focused or disease-specific approaches, it integrates personalized data, biometric analysis, and patient empowerment to intervene early and holistically, addressing root causes rather than managing outcomes. It unifies metabolic, nutritional, and mind-body modalities under a shared theory that lasting health change requires transforming the internal terrain in which disease arises.METABOLIC TERRAIN INSTITUTE OF HEALTH I
- Translational Research Acceleration 1 orgBy bridging scientific discovery and clinical application through integrated research models, organizations accelerate medical innovation and improve patient outcomes, because reducing the gap between lab findings and real-world treatment enables faster, more effective solutions for unmet health needs. This strategy emphasizes a deliberate, structured pathway from basic science to clinical impact, unifying diverse efforts such as genomic analysis, biospecimen sharing, cross-species oncology, and bench-to-bedside collaboration. Unlike general research funding or isolated lab work, this approach prioritizes bidirectional flow between researchers and clinicians, ensuring that discoveries are not only scientifically sound but also clinically actionable. It is distinguished by its focus on process acceleration—via data standardization, pre-competitive collaboration, or rapid translation—rather than discovery alone.THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE